Publications

Publications 1996

CISPLATIN AND CONTINUOUS INFUSION OF FLUOROURACIL FOLLOWED BY RADIATION OF WEEKLY CARBOPLATIN IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER

G. Fountzilas, P. Kosmidis, K.S. Shridhar, A. Kalogera-Fountzila, K. Banis, A. Dimitriadis, V. Avramidis, A. Nikolaou, T. Zaramboukas, D. Skarlos, A. Vritsios, I. Daniilidis

Cancer Invest 1996;14(3):189-96


 

A PHASE II STUDY OF PACLITAXEL IN ADVANCED BREAST CANCER RESISTANT TO ANTHRACYCLINES

G. Fountzilas, A. Athanassiadis, T. Giannakakis, D. Bafaloukos, K. Karakousis, N. Dombros, P. Kosmidis, D. Skarlos

Eur J Cancer 1996 Jan;32A(1):47-51


 

PROGNOSTIC VARIABLES IN PATIENTS WITH ADVANCED COLORECTAL CANCER TREATED WITH FLUOROURACIL AND LEUCOVORIN-BASED CHEMOTHERAPY

G. Fountzilas, K. Gossios, A. Zisiadis, E. Svarna, D. Skarlos, N. Pavlidis

Med Pediatr Oncol 1996 May;26(5):305-17


 

CARBOPLATIN ALONE COMPARED WITH ITS COMBINATION WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE IN UNTREATED ADVANCED EPITHELIAL OVARIAN CANCER: HECOG

D.V.Skarlos, G. Aravantinos, P. Kosmidis, N. Pavlidis, K. Gennatas, M. Beer, N. Mylonakis, P. Makrantonakis, G. Klouvas, S. Karpathios, H. Linardou, C. Konstantaras, G. Fountzilas

Eur J Cancer 1996 Mar;32A(3):421-8


 

RECOMBINANT INTERFERON ALFA-2A IN COMBINATION WITH CARBOPLATIN, VINBLASTINE AND BLEOMYCIN IN THE TREATMENT OF ADVANCED MALIGNANT MELANOMA

D. Bafaloukos, N. Pavlidis, G. Fountzilas, D. Skarlos, G. Klouvas, P. Makrantonakis, T. Giannakakis, N. Tsavaris, P. Kosmidis

Am J Clin Oncol 1996 Jun;19(3):296-300


 

PACLITAXEL AND CARBOPLATIN IN NON-OPERABLE NON-SMALL CELL LUNG CANCER

P. Kosmidis, N. Mylonakis, G. Fountzilas, E. Samantas, A. Athanasiadis, D. Skarlos

Semin Oncol 1996 Dec;23(6 Suppl 16):68-70


 

A PROSPECTIVE RANDOMIZED PHASE III STUDY IN NON-SMALL-CELL LUNG CANCER COMPARING CISPLATIN, IFOSFAMIDE, VINBLASTINE (VIP) VERSUS CISPLATIN, IFOSFAMIDE AND ETOPOSIDE (VIP - 16)

P. Kosmidis, N. Mylonakis, G. Fountzilas, N. Pavlidis, E. Samantas, A. Karabelis, K. Kattis, D. Skarlos

Ann Oncol 1996 Jul;7(5):517-20


 

CLINICAL VALUE OF CA 15-3, MUCIN-LIKE CARCINOMA-ASSOCIATE ANTIGEN, TUMOR POLYPEPTIDE ANTIGEN, AND CARCINOEMBRYONIC ANTIGEN IN MONITORING EARLY BREAST CANCER PATIENTS

D. Pectasides, N. Pavlidis, L. Gogou, F. Antoniou, C. Nicolaides, D. Tsikalakis, G. Fountzilas

Am J Clin Oncol 1996 Oct;19(5):459-64


 

CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUOROURACIL VERSUS CONVENTIONAL CMF AS ADJUVANT TREATMENT IN NODE-POSITIVE BREAST CANCER PATIENTS

G. Fountzilas, A. Polichronis, K. Katsohis, K. Gennatas, D. Toussis, D. Skarlos, P. Kosmidis, S. Vassilaros, C. Semoglou, T. Giannakakis, E. Fahantidis, G. Klouvas, N. Tsavaris, C. Konstantaras, P. Makrantonakis, C. Kolotas, N. Zamboglou, S. Tsiliakos, D. Hainoglou, N. Mylonakis, N. Pavlidis

Oncology 1996 Mar-Apr;53(2):137-46


 

PHASE II STUDY OF 5-FLUOROURACIL AND INTERFERON-GAMMA IN PATIENTS WITH METASTATIC COLORECTAL CANCER

N. Pavlidis, C. Nicolaides, A. Athanassiades, K. Beriatou, D. Skarlos, Th. Giannakakis, P. Kosmidis, N. Karvounis, G. Fountzilas

Oncology 1996 Mar-Apr;53(2):159-62


 

SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMA

N. Pavlidis, C. Nikolaides, E. Bairaktari, J. Kalef-Ezra, A. Athanassiadis, C. Seferiadis, G. Fountzilas

Int J Biol Markers 1996 Jan-Mar;11(1):6-1


 

WIDESPREAD CASTLEMAN DISEASE: CT FINDINGS

K. Gossios, C. Nicolaides, M. Bai, G. Fountzilas

Eur Radiol 1996;6(1):95-8


 

FLUORURACIL AND LEUCOVORIN WITH OR WITHOUT INTERFERON ALFA-2b IN ADVANCED COLORECTAL CANCER: ANALYSIS OF A PROSPECTIVE RANDOMIZED PHASE II TRIAL

P.A. Kosmidis, N. Tsavaris, D. Skarlos, D. Theocharis, E. Samantas, N. Pavlidis, E. Briassoulis, G. Fountzilas

J Clinl Oncol 1996 Oct;14(10):2682-7


 

THE BENEFICIAL EFFECT OF TAMOXIFEN ON SERUM LIPOPROTEIN-A LEVELS: AN ADDITIONAL ANTI-ATHEROGENIC PROPERTY

M. Elisaf, E. Bairaktari, C. Nicolaides, G. Fountzilas, C. Tzallas, K. Siamopoulos, O. Tsolas, N. Pavlidis

Anticancer Res 1996 Sep-Oct;16(5A):2725-8

 


 

OVARIAN ABLATION IN EARLY BREAST CANCER: OVERVIEW OF THE RANDOMISED TRIALS. EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP

Lancet 1996 Nov 2;348(9036):1189-96